Synthetic cannabinoids: The newest, almost illicit drug of abuse

Emergency Medicine

Volumn 43, Issue 2, 2011, Pages 26-28

  Lapoint, Jeff ^a   Nelson, Lewis S ^a  

^a University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955498254     PISSN: 00136654     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Atwood BK, Huffman J, Straiker A, Mackie K. JWH018, a common constituent of 'spice' herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist. Br J Pharmacol. 2010;160(3):585-593.
2. Vardakou I, Pistos C, Spiliopoulou Ch. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157-162.
3. Schneir AB, Cullen J, Ly BT. "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med. 2010 Dec [Epub ahead of print].
4. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Thematic papers: Understanding the 'spice' phenomenon. Lisbon: November 2009. www. emcdda.europa.eu/html.cfm/index90917EN.html. Accessed February 5, 2011.
5. DEA moves to emergency control synthetic marijuana: agency will study whether to permanently control five substances [press release]. Washington, DC: US Drug Enforcement Administration; November 24, 2010.
6. Treatment of Controlled Substance Analogues, 21 USC §813 (2010).